Detalhe da pesquisa
1.
Histological demonstration of BSEP/ABCB11 inhibition in transient neonatal cholestasis: a case report.
BMC Pediatr;
20(1): 340, 2020 07 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32646411
2.
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
J Hepatol;
64(3): 674-81, 2016 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26529078
3.
Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia.
Hepatology;
59(3): 858-69, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24002947
4.
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCOâ»3 output.
Hepatology;
54(4): 1303-12, 2011 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22006858
5.
Primary sclerosing cholangitis: new approaches to diagnosis, surveillance and treatment.
Dig Dis;
30 Suppl 1: 39-47, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23075867
6.
Targeting nuclear bile acid receptors for liver disease.
Dig Dis;
29(1): 98-102, 2011.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21691114
7.
Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.
Gut;
59(4): 521-30, 2010 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20332524
8.
New insights into autoimmune cholangitis through animal models.
Dig Dis;
28(1): 99-104, 2010.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20460897
9.
Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice.
Liver Int;
28(7): 948-58, 2008 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18410282
10.
Clinical application of transcriptional activators of bile salt transporters.
Mol Aspects Med;
37: 57-76, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24333169
11.
Nuclear receptors as drug targets in cholestatic liver diseases.
Clin Liver Dis;
17(2): 161-89, 2013 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23540496
12.
Farnesoid X receptor represses hepatic human APOA gene expression.
J Clin Invest;
121(9): 3724-34, 2011 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21804189